ZA955865B - The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia - Google Patents

The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia

Info

Publication number
ZA955865B
ZA955865B ZA955865A ZA955865A ZA955865B ZA 955865 B ZA955865 B ZA 955865B ZA 955865 A ZA955865 A ZA 955865A ZA 955865 A ZA955865 A ZA 955865A ZA 955865 B ZA955865 B ZA 955865B
Authority
ZA
South Africa
Prior art keywords
adenosyl
methionine
same
damage caused
physiologically tolerated
Prior art date
Application number
ZA955865A
Other languages
English (en)
Inventor
Laszio Szabo
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA955865B publication Critical patent/ZA955865B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA955865A 1994-07-16 1995-07-14 The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia ZA955865B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4425280A DE4425280C2 (de) 1994-07-16 1994-07-16 Verwendung von (S)-Adenosyl-L-methionin und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die nach temporärer fokaler Ischämie ausgelöst werden

Publications (1)

Publication Number Publication Date
ZA955865B true ZA955865B (en) 1997-01-14

Family

ID=6523426

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955865A ZA955865B (en) 1994-07-16 1995-07-14 The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia

Country Status (18)

Country Link
US (1) US5776911A (hr)
EP (1) EP0771202A1 (hr)
JP (1) JPH10502652A (hr)
KR (1) KR970704442A (hr)
AU (1) AU2927195A (hr)
BG (1) BG101145A (hr)
CA (1) CA2195345A1 (hr)
CZ (1) CZ12297A3 (hr)
DE (1) DE4425280C2 (hr)
FI (1) FI970165A (hr)
HR (1) HRP950405A2 (hr)
HU (1) HUT76834A (hr)
IL (1) IL114540A0 (hr)
NO (1) NO970185L (hr)
PL (1) PL318318A1 (hr)
SI (1) SI9520087A (hr)
WO (1) WO1996002252A1 (hr)
ZA (1) ZA955865B (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
IT1317920B1 (it) * 2000-10-20 2003-07-15 Univ Roma S-adenosilmetionina e suoi derivati per il trattamento e laprevenzione della malattia di alzheimer.
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US7902423B2 (en) * 2005-04-20 2011-03-08 Basf Plant Science Gmbh Expression cassettes for seed-preferential expression that utilize the promoter from a flax tonoplast intrinsic protein gene
CA2718469C (en) 2008-03-17 2017-07-04 National Research Council Of Canada Aromatic prenyltransferase from hop

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
JPH0770235B2 (ja) * 1988-06-24 1995-07-31 株式会社東芝 不揮発性メモリ回路装置
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体

Also Published As

Publication number Publication date
HU9700130D0 (en) 1997-02-28
NO970185D0 (no) 1997-01-15
SI9520087A (en) 1997-08-31
CZ12297A3 (cs) 1998-04-15
HUT76834A (en) 1997-11-28
EP0771202A1 (de) 1997-05-07
BG101145A (en) 1997-08-29
US5776911A (en) 1998-07-07
DE4425280A1 (de) 1996-01-18
WO1996002252A1 (de) 1996-02-01
MX9700439A (es) 1998-05-31
IL114540A0 (en) 1995-11-27
DE4425280C2 (de) 1997-05-07
FI970165A (fi) 1997-03-14
CA2195345A1 (en) 1996-02-01
PL318318A1 (en) 1997-06-09
NO970185L (no) 1997-03-12
JPH10502652A (ja) 1998-03-10
FI970165A0 (fi) 1997-01-15
HRP950405A2 (en) 1997-10-31
AU2927195A (en) 1996-02-16
KR970704442A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
ZA955642B (en) Lyophilized imaging agent formulation
DK1468679T3 (da) Tramadolholdig formulering med styret frigivelse
HK1001618A1 (en) Novel pyrimidine derivatives and processes for the preparation thereof
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
EP0499260A3 (en) Procedure for hydrolyzing keratin
EP0660719A4 (en) METHOD AND COMPOSITION TO PREVENT TISSUE DAMAGE AS A CONSEQUENCE OF ISCHEMIA AND REPERFUSION.
KR960007633A (ko) 고강성 프로필렌-에틸렌 블록 공중합체 조성물 및 이의 제조방법
GB9709360D0 (en) Methods for the treatment of herpes virus infections
MX25231A (es) Compuestos de carbapenem y procedimiento para su preparacion.
ZA918074B (en) N-(2-alkyl-3-mercaptoglutaryl)-amino-diaza cycloakanone derivatives and their use as collage/nase inhibitors.
GB9410252D0 (en) Galenic formulations
AU9052991A (en) Use of angiotensin ii antagonist in the treatment of infarction
ZA955865B (en) The use of (s)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia
TR25269A (tr) SüBSTITüE EDILMIS BENZANILIDLER VE ILISKILI BENZILAMINLER, HAZIRLANMALARINA MAHSUS USULLER VE HERBISID OLARAK KULLANIMLARI
HUP9902963A3 (en) Process for the preparation of amino alcohols and derivatives thereof
MX9101794A (es) Compuestos de trifendioxazina y procedimiento para su preparacion
MX9100779A (es) Compuestos azabiciclicos y procedimiento para su preparacion
IL115537A0 (en) Phosphonosulfonate salts pharmaceutical compositions containing the same and methods for the preparation thereof
FI954348A (fi) Säädetysti vapauttava alumiinia sisältävä farmaseuttinen valmiste
IL115197A (en) Vaccine preparations for preventing vaginal infections
DE59309194D1 (de) Aktive clamping-schaltung
GB9603657D0 (en) Improvements in the treatment of vaginal infections
ITPD930207A0 (it) Scacchiera perfezionata
MX9200282A (es) Derivados de aminoacido y procedimiento para su preparacion.
IL111460A0 (en) Composition for the treatment of viral infections